IndraLab

Statements


TNFAIP3 inhibits CCL2. 1 / 1
| 1

reach
"Furthermore, when compared with TNFAIP3 non knockdown and UBE2L3 knockdown in human HeLa cells, TNFAIP3 knockdown and UBE2L3 non knockdown synergistically increase three cytokines, CCL2, CXCL8 (IL8), and IL6, all regulated by NF-kappaB in the human TNFR signaling pathway."